Trials / Withdrawn
WithdrawnNCT02153424
Early Post-marketing Study of Eliquis (Apixaban)
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of the study is to identify and describe any suspected (AEs) in all patients with NVAF treated with Apixaban, as a request of the National Center of Pharmacovigilance (CNFV) in Mexico.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Apixaban |
Timeline
- Start date
- 2014-04-01
- Primary completion
- 2015-11-01
- Completion
- 2015-11-01
- First posted
- 2014-06-03
- Last updated
- 2016-08-17
Locations
2 sites across 1 country: Mexico
Source: ClinicalTrials.gov record NCT02153424. Inclusion in this directory is not an endorsement.